Papers

3

Total Citations

177

H-Index

3

About

Patrick W. Serruys is a towering figure in interventional cardiology, whose pioneering work has fundamentally reshaped the treatment of coronary artery disease. His research spans the full spectrum of revascularization, from the development and clinical validation of drug-eluting stents and bioresorbable scaffolds to advanced imaging and lipidomics. A landmark contribution is his investigation into molecular lipid species, where his team demonstrated that specific ceramide ratios in plasma powerfully predict long-term major adverse cardiac events in coronary artery disease patients—a study that has garnered 157 citations and opened new avenues for personalized risk stratification. Serruys has also been instrumental in establishing guidelines for reporting outcomes after cardiac valve interventions, ensuring rigor and comparability across clinical trials. His visionary perspective is evident in his forward-looking analyses, such as forecasting the trajectory of coronary revascularization through 2040, building on his earlier accurate predictions of innovations like drug-eluting stents and coronary CT angiography. With a career spanning decades and an enduring impact on clinical practice, Serruys remains a guiding force in cardiovascular medicine.

Research Focus

Key Achievements

3
H-Index
3
Papers
177
Total Citations
59
Avg Citations/Paper
🏆 Most Cited Paper
Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients
157 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Imperial College London, Ollscoil na Gaillimhe – University of Galway

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago